help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on May 31, 2007
Endocrinology, doi:10.1210/en.2007-0348
A more recent version of this article appeared on September 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
148/9/4302    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Puglisi, R.
Right arrow Articles by Boitani, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Puglisi, R.
Right arrow Articles by Boitani, C.

Submitted on March 13, 2007
Accepted on May 24, 2007

Mice overexpressing the mitochondrial Phospholipid Hydroperoxide Glutathione Peroxidase in male germ cells show abnormal spermatogenesis and reduced fertility

Rossella Puglisi, Arturo Bevilacqua, Gianfranco Carlomagno, Andrea Lenzi, Loredana Gandini, Mario Stefanini, Franco Mangia, and Carla Boitani*

Department of Histology & Medical Embryology, Department of Psychology, Section of Neuroscience, Department of Medical Pathophysiology, Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome, Italy

* To whom correspondence should be addressed. E-mail: carla.boitani{at}uniroma1.it.

To investigate the physiological effects of mPHGPx overexpression during early male germ cell differentiation, we have generated transgenic mice bearing the rat mPhgpx coding sequence driven by the mouse Synaptonemal Complex Protein 1 promoter, allowing the transgene to be specifically activated in the testis from the zygotene to diplotene stages of the first meiotic division. Northern/western blotting and immunocytochemical analyses of endogenous mPHGPx expression during spermatogenesis showed a low enzyme level in middle-late pachytene spermatocytes, but not in earlier meiotic stages, and a significant increase in mPHGPx content in round spermatids. The histological and TUNEL analysis of transgenic testes revealed a number of spermatogenetic defects, including primary spermatocytes apoptosis, haploid cell loss and seminiferous epithelium disorganization. In line with these features, adult transgenic male mice also displayed a reduction in fertility. Results obtained in this study suggest that mPHGPx expression is tightly regulated in pachytene spermatocytes, any spatial-temporal increase in mPHGPx expression resulting in a damage to spermatogenesis and eventual loss of haploid cells. Present findings in the mouse may be of interest to human male fertility.


Key words: mPHGPx • selenium • spermatocytes • apoptosis • male fertility







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society